EP Global Communications Inc fka EPGL

[vikingzskillz]

Must read! EPGL shareholder Q & A session via Twitter 9-5-2012


@EPGLMed
Thanks to all shareholders who joined tonight's Q&A. Please monitor Twitter for alerts on PRs and other announcements.

@EPGLMed
Pavao, Yes we encourage all EPGL shareholders to make their personal doctors aware of MPDD. You are the owners of EPGL.

@EPGLMed
Lonnie, yes, we plan to become fully reporting by year end with OTC and SEC. Doing housekeeping to that end right now.

@EPGLMed
Viking, we plan to market US only first half 2013, then open Europe and Asia distribution second half 2013

@EPGLMed
Viking we will release a prospectus with sales projections. Suffice to say, we believe the potential is there to sell more than 10,000 2013

@EPGLMed
Sean MPTT is one of the devices we are R&D stage with. To treat chronic pain as complimentary to the MPDD.

@EPGLMed
Sean, yes new devices are in R&D, but total focus is on MPDD now.

@EPGLMed
Bill, additional doctors and scientists along with company management will be announced in coming days.

@EPGLMed
Website http://www.epglmed.com will open up within 10 days or sooner.

@EPGLMed
Hank, the MPDD device has been extensively researched here at NYU and among research doctors. It works rather well.

@EPGLMed
Sharma, we are making moves to make EPGL trade as easy as possible with all brokers. There has been a lot of housekeeping to do.

@EPGLMed
Major equity holders plan to hold EPGL for duration of major growth period. Interested in return on investment as with shareholders.

@EPGLMed
Sharma, major equity holders only interested in selling as a block in future to another company or major investor. Not selling retail.

@EPGLMed
Henry, we want to keep manufacturing in US, but must keep options open for Europe and Asia as demand grows in those regions.

@EPGLMed
Early devices have been produced in US.

@EPGLMed
Roger, current share structure 5 billion authorized, 499 million outstanding in float. 4.5 billion restricted.

@EPGLMed
John, EPGL will begin to move up tiers on Pink sheets shortly and plans to move off Pink sheets to OTCQX

@EPGLMed
Q&A will go until 6:15 PM EST

@EPGLMed
Kyle, the new equity partners are fully committed to the growth of this new company which will be changing names shortly.

@EPGLMed
Kyle, we will not fund the company with dilution, period. We will not enter into any PIPE financing arrangements.

@EPGLMed
Klaas, production of MPDD has already started as there are devices existing, but major numbers will be starting in first quarter.

@EPGLMed
Matt we have been in discussions with at least 2 large medical device companies, but nothing has been decided as yet.

@EPGLMed
Matt, yes we have had conversations with other major medical device makers about distribution and strategic partnerships.

@EPGLMed
Matt, 499,161,167 shares are outstanding and in the float. The remaining authorized are restricted

@EPGLMed
Matt, we are funding business operations from major equity holders funds.

@EPGLMed
Kyle, we will release a prospectus for shareholders before year end with sales projections.

@EPGLMed
Klaas, we will release initial financials before year end and become fully reporting.

@EPGLMed
Klaas, we expect to be profitable in 2013 as EPGL has very little debt and significant revenues in the forecast.

@EPGLMed
EPGL is well connected with the U.S. Military and major HMO's

@EPGLMed
Victor As far as major purchase contracts, we cannot comment in detail on that at this time. But that is a major interest and is on radar.

@EPGLMed
Victor, Launch By first quarter 2013, but orders are already coming in advance.

@EPGLMed
Brian Yes, we will have a stock awareness program going within 30 days if not sooner. We have been approached by many firms that do this.

@EPGLMed
Brian, MPDD is a device that can be used by any physician who needs to determine cause of chronic muscle pain. That means most can use.

@EPGLMed
Brian, the MPDD has appeal to all physicians, primary care, pain physicians and physical therapists.

@EPGLMed
Brian there are over 600,000 physicians in US alone and estimated 15 million worldwide.

@EPGLMed
We are answering questions in the order they are being received and will answer as many as possible until 6 PM EST.

@EPGLMed
Brian, $12,000.00 per unit is $1mm revenue per 100 orders. That does not include recurring training and upgrades.

@EPGLMed
Brian, Absolutely we believe in $3.5 billion annual market potential revenues.

@EPGLMed
EPGL shareholders are very much appreciated and for those participating here, tonight thank you.

@EPGLMed
Q&A will last 30 minutes

@EPGLMed
Live Q&A session for EPGL investors at 5:30PM EST today. Submit questions to [e-mail]